AMG 386 and Abiraterone for Advanced Prostate Cancer

Clinical trial NCT01553188 · COMPLETED

Trial details

NCT number: NCT01553188
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms Prostate Cancer Neoplasm, Prostate Neoplasm,Prostatic

Start date: 2012-02-08
Primary completion: 2017-04-20
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.